• Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Throat Phlegm Relief from Vitaae®: Natural Support for Women Battling Long COVID and Menopausal Brain Inflammation Available For Amazon Prime Day


News provided by

SANEMD

Oct 07, 2024, 07:00 ET

Share this article

Share toX

Share this article

Share toX


Throat Phlegm Relief from Vitaae®: Natural Support for Women Battling Long COVID and Menopausal Brain Inflammation Available For October's Amazon Prime Day 2024

BELLEVUE, Wash., Oct. 7, 2024 /PRNewswire-PRWeb/ -- Throat Phlegm Relief from Vitaae®: Natural Support for Women Battling Long COVID and Menopausal Brain Inflammation Available For October's Amazon Prime Day 2024!

Vitaae® helps the body address the compounded challenges women face from long COVID and menopause, offering relief for persistent throat phlegm, brain fog, and inflammation.

Throat Phlegm Relief from Vitaae®: Natural Support for Women Battling Long COVID and Menopausal Brain Inflammation

Post this

Learn More About Vitaae® Here

As COVID-19 resurges, many women are dealing with a double burden: the lingering symptoms of long COVID alongside the inflammatory changes brought on by menopause. Long COVID, also known as post-COVID conditions or PASC, refers to symptoms persisting for weeks or even months after an infection has cleared. According to the Centers for Disease Control and Prevention (CDC), 5.3% of adults in the U.S. reported experiencing long COVID (1). This syndrome disproportionately affects women, especially those aged 40 to 59 (1)—an age group already navigating significant hormonal shifts due to perimenopause and menopause. The decline in estrogen during menopause can trigger neurological inflammation (2), compounding the symptoms of long-term COVID, such as brain fog and persistent throat phlegm.

In response, SANE MD is proud to announce that Vitaae®, a supplement formulated to help the body combat brain-based inflammation, is now available on Amazon for a limited time. Vitaae® offers a natural and innovative approach to support the body in alleviating these troubling symptoms by targeting the neurological inflammation at its root.

COVID-19 and Brain Inflammation in Women

COVID-19 has been shown to cause neuroinflammation, where the body's immune response to the virus leads to prolonged inflammation in the brain (3). This is particularly concerning for women going through menopause, as the decline in estrogen increases overall inflammation, compounding both cognitive and respiratory symptoms. These can include issues such as brain fog, persistent throat phlegm, and coughing, which often linger long after the infection has cleared.

"Scientific evidence (4) suggests that hormonal changes during menopause, particularly the decline in estrogen, increase the risk of developing inflammatory autoimmune conditions, such as rheumatoid arthritis, thyroid disorders, and even multiple sclerosis," explains Dr. Matthew Olesiak, MD, Chief Medical Director at SANE MD. "This drop in estrogen also heightens neuroinflammation, driven by glial cells in the brain. When combined with the immune response from viral infections like COVID-19, it creates a double whammy for women, intensifying symptoms like brain fog, cognitive decline, and respiratory discomfort, making the experience significantly more burdensome."

How Menopause Worsens Brain Inflammation

As women enter menopause, estrogen—a hormone with anti-inflammatory properties—begins to decline, leaving the brain more susceptible to inflammation. This can lead to cognitive symptoms, such as memory lapses, mood swings, and brain fog, all of which are worsened by long COVID. Additionally, menopause-related inflammation increases IL-6 and TNF-α, inflammatory markers directly linked to long COVID, further aggravating symptoms such as chronic cough and excess mucus production.

Vitaae®: Comprehensive Support To Help The Body Address Long COVID and Menopausal Inflammation

Vitaae® contains a carefully curated blend of ingredients specifically designed to help the body combat brain inflammation, offering comprehensive support to help the body address both long COVID and menopausal symptoms. Key ingredients include:

  • Citicoline: Proven to improve brain energy, attention, and motor function, this compound can help the body reduce brain inflammation caused by both long COVID and menopause (5).
  • Acetyl-L-carnitine: A key nutrient that supports mitochondrial function and helps the body reduce inflammation in the brain.
  • CoQ10 and Folate: Together, these ingredients further support brain health, helping to support improved cognitive function while helping to reduce physical discomfort like persistent phlegm production.

By helping the body address brain inflammation at its source, Vitaae® helps regulate mucus production, which can be triggered by overactive glial cells during both viral infections and menopausal transitions. Women experiencing both long COVID and menopause may find great help from the compounded effects of these conditions with Vitaae®'s anti-inflammatory properties.

A New Hope for Women Facing Long COVID and Menopause

Women facing both long COVID and the inflammatory effects of menopause are often left searching for solutions to combat symptoms like persistent coughing, throat irritation, mental fatigue, and cognitive decline. Vitaae® offers natural support by helping the body tackle the neurological inflammation at the core of these issues, supporting mental clarity, energy, and physical relief.

"At SANE MD, we focus on helping the body address the root causes of chronic health conditions," adds Jonathan Bailor, Founder and CEO of SANE MD. "Whether or not you're experiencing menopause, Vitaae® is uniquely positioned to provide tremendous help for anyone dealing with neuroinflammation. It can help the body target the overlapping challenges of long COVID, brain fog, and inflammation, offering both physical and cognitive assistance through innovative brain health solutions."

Vitaae® is available for purchase on Amazon for a limited time. Those looking for natural relief from long COVID symptoms and/or menopausal brain inflammation can find out more or make a purchase by visiting Vitaae® Prime Day Here

About SANE MD:

SANE MD is a wellness technology and metabolic healing company dedicated to ending the Diabesity (diabetes plus obesity) epidemic. Backed by 1,300 clinical studies and thousands of success stories, SANE MD's metabolic healing framework and model is the only program of its kind endorsed by top doctors, scientists, and researchers around the world, and is the subject of New York Times best-selling books, and award-winning documentaries. Started as a not-for-profit research project by a ten-year Microsoft alum, Jonathan Bailor, SANE MD has transformed into a trusted international wellness brand focused on reversing the most common and devastating modern diseases. Using the latest innovations in biochemical research and a "service-first story-based" marketing approach to reach, lift up, and educate consumer health choices, SANE MD is changing the world of wellness by helping everyone from the underprivileged to the Fortune 500 CEO regain their "SANEity" one new "SANE" consumer at a time. SANE MD was inducted into Inc. 5000's list of "Fastest-Growing Private Companies in America" for 2020. For more information, visit: SANE Solution.

SANE Vitaae™ Ingredients:

  • Vitamin D (as cholecalciferol)
  • Folate (as 5-MTHF from Calcium Methyltetrahydrofolate)
  • Acetyl L-carnitine HCL
  • L-Carnitine Tartrate
  • Gymnema sylvestre Leaf Extract 25% Gymnemic Acid
  • Omega-3 Fish Oil Microencapsulated (9% EPA, 6% DHA)
  • Citicoline Sodium (CDP-Choline)
  • CoQ10 (as HydroQsorb®)
  • Other ingredients: Gelatin, magnesium stearate, silica, and rice flour.

Scientific References

1- https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm

2- https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-01998-9

3- https://covid19.nih.gov/news-and-stories/inflammation-pattern-brain-may-cause-many-long-covid-symptoms

4- https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2019.00265/full

5- The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males - PubMed (nih.gov)

Media Contact

Jonathan Bailor, SANEMD, 1 347 979-1735, [email protected], https://sanesolution.com

SOURCE SANEMD

Modal title

Vitaae Prime Day
Vitaae Prime Day
Vitaae Prime Day

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2024 Cision US Inc.